Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Kevin R Bainey"'
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254008 (2021)
Estimates of the risk of recurrent cardiovascular events (residual risk) among patients with acute coronary syndromes have largely been based on clinical trial populations. Our objective was to estimate the residual risk associated with common comorb
Externí odkaz:
https://doaj.org/article/28b714938c7847b1b367db703dba3e12
Autor:
Laurie-Anne Boivin-Proulx, MD, MSc, Kevin R. Bainey, MD, MSc, Guillaume Marquis-Gravel, MD, Michelle M. Graham, MD
Publikováno v:
CJC Open, Vol 6, Iss 5, Pp 677-688 (2024)
Background: Balancing the effects of dual antiplatelet therapy (DAPT) in the era of potent purinergic receptor type Y, subtype 12 (P2Y12) inhibitors remains a challenge in the management of acute coronary syndrome (ACS). Methods: We conducted a syste
Externí odkaz:
https://doaj.org/article/8d6613b567574ab4a5ae19db4d8361f7
Autor:
Ahmad Hayek, MD, Blair J. MacDonald, BA PharmD, Guillaume Marquis-Gravel, MD, MSc, Kevin R. Bainey, MD, MSc, Samer Mansour, MD, Margaret L. Ackman, PharmD, Warren J. Cantor, MD, Ricky D. Turgeon, BSc(Pharm), PharmD
Publikováno v:
CJC Open, Vol 6, Iss 5, Pp 708-720 (2024)
Background: Ongoing debate remains regarding optimal antithrombotic therapy in patients with atrial fibrillation (AF) and coronary artery disease. Methods: We performed a systematic review and meta-analysis to synthesize randomized controlled trials
Externí odkaz:
https://doaj.org/article/64896edc917548ddace1fecbe9a31191
Autor:
Chloë Laferrière, MD, Chloé Moazzami, MD, Emilie Belley-Côté, MD, PhD, Kevin R. Bainey, MD, MSc, Guillaume Marquis-Gravel, MD, MSc, Alexa Fama, Marie Lordkipanidzé, BPharm, PhD, Brian J. Potter, MDCM, SM
Publikováno v:
CJC Open, Vol 5, Iss 12, Pp 881-890 (2023)
Background: Since the publication of the 2010 Canadian antiplatelet guidelines, several large randomized controlled trials (RCTs) have evaluated the role of aspirin (ASA) use in primary prevention. We evaluated the effect of ASA use, compared with no
Externí odkaz:
https://doaj.org/article/7ba80420a7ea47b4a3bf965d05b3e0e4
Influenza H1N1 infection leading to cardiac tamponade in a previously healthy patient: A case report
Publikováno v:
Research in Cardiovascular Medicine, Vol 5, Iss 3, Pp 6-6 (2016)
Introduction: The cardiac manifestations of influenza A are broad, ranging from self-limited pericarditis to fatal cardiomyopathy. The 2009 H1N1 influenza A (H1N1) strain is a rare cause of pericarditis, and its role in developing a pericardial effus
Externí odkaz:
https://doaj.org/article/8a123c39218748caa17c9c1964ca2ad8
Autor:
Jacob A. Udell, Bahar Behrouzi, Atul Sivaswamy, Anna Chu, Laura E. Ferreira-Legere, Jiming Fang, Shaun G. Goodman, Justin A. Ezekowitz, Kevin R. Bainey, Sean van Diepen, Padma Kaul, Finlay A. McAlister, Isaac I. Bogoch, Cynthia A. Jackevicius, Husam Abdel-Qadir, Harindra C. Wijeysundera, Dennis T. Ko, Peter C. Austin, Douglas S. Lee
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract We aimed to determine whether early public health interventions in 2020 mitigated the association of sociodemographic and clinical risk factors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a popul
Externí odkaz:
https://doaj.org/article/750cb19223064b079f27bb1a0e80dae0
Autor:
Kevin R. Bainey, Guillaume Marquis-Gravel, Blair J. MacDonald, David Bewick, Andrew Yan, Ricky D. Turgeon
Publikováno v:
PLoS ONE, Vol 18, Iss 9 (2023)
Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However, DAPT duration is a concern in high bleeding risk (HBR) patients. We eva
Externí odkaz:
https://doaj.org/article/46d7a344ace94193a2ab1bb45539be6a
Autor:
Kevin R. Bainey, MD, MSc, Ahmed Abulhamayel, MD, Amir Aziz, MRCP, PhD, Harald Becher, MD, PhD
Publikováno v:
CJC Open, Vol 4, Iss 7, Pp 644-646 (2022)
Reperfusion injury is common following primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction. In a prospective Canadian single-arm study of 15patients, the use of myocardial contrast echocardiography with high mechani
Externí odkaz:
https://doaj.org/article/86bfb47558214ffb874410590a19cd65
Autor:
Shamir R, Mehta, Jia, Wang, David A, Wood, John A, Spertus, David J, Cohen, Roxana, Mehran, Robert F, Storey, Philippe Gabriel, Steg, Natalia, Pinilla-Echeverri, Tej, Sheth, Kevin R, Bainey, Sripal, Bangalore, Warren J, Cantor, David P, Faxon, Laurent J, Feldman, Sanjit S, Jolly, Vijay, Kunadian, Shahar, Lavi, Jose, Lopez-Sendon, Mina, Madan, Raul, Moreno, Sunil V, Rao, Josep, Rodés-Cabau, Goran, Stankovic, Shrikant I, Bangdiwala, John A, Cairns, Dhananjai, Menzies
Publikováno v:
JAMA cardiology. 7(11)
ImportanceIn patients with multivessel coronary artery disease (CAD) presenting with ST-segment elevation myocardial infarction (STEMI), complete revascularization reduces major cardiovascular events compared with culprit lesion–only percutaneous c
Autor:
Kevin R. Bainey, Wendimagegn Alemayehu, Robert C. Welsh, Arnav Kumar, Spencer B. King, Ajay J. Kirtane
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 1 (2021)
Background The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial failed to show a reduction in hard clinical end points with an early invasive strategy in stable ischemic heart disease (SIHD
Externí odkaz:
https://doaj.org/article/e7f1c966a3294fde9c01107e16204564